Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank86
Studio
Year-over-Year Change

Enterprise value to sales ratio

Percentile
P86
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20253.27-74.3%
202412.72-99.2%
20231574.93-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-